Sage Journals: Discover world-class research

Open access

Review article

First published 2021

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Heinz Wiendl, Ralf Gold, Thomas Berger [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Review article

First published 2019-10

The emergence of follow-on disease-modifying therapies for multiple sclerosis

Brandon P Moss, Jeffrey A Cohen

Multiple Sclerosis Journal

Retricted access

Research article

First published 2020-10

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies

Marisa P McGinley, Philip A Cola, Robert J Fox [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-7

The effect of disease modifying therapies on CD62L expression in multiple sclerosis

Margarete Maria Voortman, Paul Greiner, Daniel Moser [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2021

Health economics of disease-modifying therapy for multiple sclerosis in the United States

Daniel M. Hartung

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2016

Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice

Erin E Longbrake, Anne H Cross, Amber Salter

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2021

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age

Yinan Zhang, Amber Salter, Shan Jin [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2013-6

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis

Bruce AC Cree

Multiple Sclerosis Journal

Open access

Research article

First published 2024-4

Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies

Chantelle Murley, Emma Pettersson, Jan Hillert [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2021

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis

Gisela Zanga, Estefania Drzewiscki, Paula Tagliani [...]

Therapeutic Advances in Neurological Disorders

Search results